0001209191-21-047406.txt : 20210720
0001209191-21-047406.hdr.sgml : 20210720
20210720170439
ACCESSION NUMBER: 0001209191-21-047406
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210719
FILED AS OF DATE: 20210720
DATE AS OF CHANGE: 20210720
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Basta Steven L
CENTRAL INDEX KEY: 0001417397
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38356
FILM NUMBER: 211101826
MAIL ADDRESS:
STREET 1: 1875 S GRANT STREET SUITE 110
CITY: SAN MATEO
STATE: CA
ZIP: 94402
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VYNE Therapeutics Inc.
CENTRAL INDEX KEY: 0001566044
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 453757789
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 520 U.S. HIGHWAY 22, SUITE 204
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
BUSINESS PHONE: 800-775-7936
MAIL ADDRESS:
STREET 1: 520 U.S. HIGHWAY 22, SUITE 204
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: Menlo Therapeutics Inc.
DATE OF NAME CHANGE: 20180201
FORMER COMPANY:
FORMER CONFORMED NAME: Menlo Therapeutics, Inc.
DATE OF NAME CHANGE: 20170728
FORMER COMPANY:
FORMER CONFORMED NAME: Tigercat Pharma, Inc.
DATE OF NAME CHANGE: 20130104
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-07-19
0
0001566044
VYNE Therapeutics Inc.
VYNE
0001417397
Basta Steven L
520 U.S. HIGHWAY 22, SUITE 204
BRIDGEWATER
NJ
08807
1
0
0
0
Stock Options
2.75
2021-07-19
4
A
0
20500
0.00
A
2031-07-19
Common Stock
20500
20500
D
These options vest over a 12 month period in equal, monthly installments, ending July 19, 2022.
/s/ Mutya Harsch, attorney-in-fact for Steven Basta
2021-07-20